Special CV Med and CVI Talk: Novel Biomarker Discovery in the Framingham Heart Study

When:
July 14, 2015 @ 2:30 pm – 3:30 pm
2015-07-14T14:30:00-07:00
2015-07-14T15:30:00-07:00
Where:
Falk Research Center Library
870 Quarry Road
Palo Alto, CA 94304
USA
Cost:
Free
Contact:
Department of Medicine
650-721-1166
Special CV Med and CVI Talk: Novel Biomarker Discovery in the Framingham Heart Study @ Falk Research Center Library | Palo Alto | California | United States

Presenter: Daniel Levy, MD
Director, Framingham Heart Study
National Heart, Lung and Blood Institute

Daniel Levy, MD, joined the Framingham Heart Study in 1984 after completing his cardiology fellowship at Harvard’s Brigham and Women’s Hospital and Harvard School of Public Health.

Dr. Levy is a Medical Officer of the National Heart, Lung, and Blood Institute and has a faculty appointment at Boston University School of Medicine, where he is Professor of Medicine. Dr. Levy has published over 200 articles in leading medical journals, and edited a book on the Framingham Heart Study titled 50 Years of Discovery. He serves on the editorial boards of the Journal of Hypertension and the American Journal of Medicine.

He became the Framingham Heart Study’s fourth director in 1994. Dr. Levy is a fellow of the American College of Cardiology and an active member of the American Heart Association’s Council on Hypertension and the American Society of Hypertension.

In addition to his research and administrative responsibilities, Dr. Levy has become actively involved as a policy maker. He served with the National High Blood Pressure Education Program and the National Cholesterol Education Program in the formulation of national hypertension and cholesterol guidelines.

Dr. Levy has been the recipient of many awards including the National Institutes of Health Director’s Award given for his research achievements at the Framingham Heart Study. His main areas of research interest include the epidemiology and genetics of hypertension, heart disease and heart failure